Results for:(62 found)
Jan 2, 2013 12:07PM on Top StocksBy TheStreet Staff

TheStreet's Adam Feuerstein gazes into his crystal ball to offer his biotechnology forecast for the new year.

Dec 27, 2012 11:51AM on Top StocksBy Minyanville.com

Biogen Idec, Pfizer, Bristol-Myers and Celgene are among companies awaiting US approval of key treatments.

Nov 21, 2012 12:04PM on Top StocksBy MSN Money Partner

Skechers is upgraded to 'positive,' and Yum Brands is initiated with an 'outperform.'

Nov 20, 2012 1:17PM on Top StocksBy TheStreet Staff

Clinical trials, drug launches and FDA approval decisions fill the calendar for these companies at the start of the new year.

Nov 9, 2012 12:33PM on Top StocksBy MSN Money Partner

Groupon is downgraded to 'equal weight,' while Isis Pharmaceuticals is upgraded to 'outperform.'

Oct 18, 2012 11:30AM on Top StocksBy Minyanville.com

Shares dip on news that the FDA needs more review time.

Tags: BIIBNVS
Oct 5, 2012 11:15AM on Top StocksBy MSN Money Partner

Zynga downgraded to 'neutral,' and First Solar is downgraded to 'negative.'

Sep 13, 2012 2:22PM on Top StocksBy Benzinga

Some stocks in the sector have seen massive gains this year, causing shorts to back off.

VIDEO ON MSN MONEY

DATA PROVIDERS

Copyright © 2014 Microsoft. All rights reserved.

Fundamental company data and historical chart data provided by Morningstar Inc. Real-time index quotes and delayed quotes supplied by Morningstar Inc. Quotes delayed by up to 15 minutes, except where indicated otherwise. Fund summary, fund performance and dividend data provided by Morningstar Inc. Analyst recommendations provided by Zacks Investment Research. StockScouter data provided by Verus Analytics. IPO data provided by Hoover's Inc. Index membership data provided by Morningstar Inc.

TOP STOCKS

How to invest when the world is in chaos

As geopolitical tensions threaten to spin out of control, investors are wondering how best to position their portfolios for the global turmoil.

More

MARKET DISPATCHES

No more Dispatches; here's where to find market news

The Market Dispatches column has been discontinued. Here's where to find the latest stock and business news on MSN Money, and the latest from market writer Charley Blaine.

More